12:00 AM
Mar 26, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

: Phase I/II started

Novelos began an open-label, U.S. Phase I/II trial to evaluate I-124-CLR1404 (LIGHT) in 20 patients with primary or...

Read the full 69 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >